36C25026Q1039.docx
DOCX document 16 KB Posted
- Attached to
- 6505--PET MRI Radiopharmaceuticals, Detroit
- Solicitation number
- 36C25026Q1039
About this file
This is a Special Notice documenting the Department of Veterans Affairs' intent to sole source a procurement for PET MRI radiopharmaceuticals for the John D. Dingell VA Medical Center in Detroit, Michigan. The VA intends to award a firm-fixed price, 1-year purchase order to Sofie Co. (21000 Atlantic Blvd., Suite 730, Dulles, VA 20166) for the period of performance October 1, 2026, through September 30, 2027. The required radiopharmaceutical products include Cu-64 Dotatate (Detectnet) at 15 doses, F18 PSMA (Pylarify) at 120 doses, F18 Fluorodeoxyglucose (FDG) at 200 doses, and F18 Neuraceq at 20 doses, with a cancellation fee associated with Pylarify (PSMA) at 22 units. All products are measured in 3-10 mCi dose increments for use in nuclear medicine PET MRI examinations. The contractor must provide packaging, transportation, manifests, and reports.
The sole source justification is based on a sources sought notice (36C25026Q0931) issued August 18-20, 2026, which received responses from five contractors. Although other contractors could provide some required products, Sofie Co. was determined to be the only vendor capable of supplying all specified radiopharmaceuticals. The solicitation number is 36C25026Q1039, with NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and a business size standard of 1,300 employees. Interested parties may submit capability statements demonstrating clear and convincing evidence that competition would be advantageous to the Government by 4:00 PM Eastern Time on September 23, 2025, to James Howard, Contract Specialist, at james.howard3@va.gov. The contracting office is located at 8888 Keystone Crossing, Cincinnati, OH 45219-2356.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SUBJECT*
PET MRI Radiopharmaceuticals, Detroit
GENERAL INFORMATION
| CONTRACTING OFFICE’S ZIP CODE* |
| 46202 |
| SOLICITATION NUMBER* |
| 36C25026Q1039 |
| RESPONSE DATE/TIME/ZONE |
| 09-23-2026 16:00 EASTERN TIME, NEW YORK, USA |
| ARCHIVE |
| 30 DAYS AFTER THE RESPONSE DATE |
| RECOVERY ACT FUNDS |
| N |
| PRODUCT SERVICE CODE* |
| 6505 |
| NAICS CODE* |
| 325412 |
| CONTRACTING OFFICE ADDRESS |
| Department of Veterans Affairs |
Network Contracting Office 10
8888 Keystone Crossing Cincinnati OH 45219-2356
POINT OF CONTACT*
James Howard Contract Specialist james.howard3@va.gov
ADDITIONAL INFORMATION
AGENCY’S URL
URL DESCRIPTION
AGENCY CONTACT’S EMAIL ADDRESS
EMAIL DESCRIPTION
Special Notice Special Notice
DESCRIPTION
| *= Required Field |
| Special Notice |
Special Notice
INTENT TO SOLE SOURCE
The Department of Veterans Affairs, VHA Regional Procurement Office Central, Network Contracting Office 10, intends to enter into a sole source procurement for PET MRI Radiopharmaceuticals for the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201. The Department of Veterans Affairs intends to award a sole source, firm-fixed price, 1-year purchase order to Sofie Co., 21000 Atlantic Blvd., Suite 730, Dulles, VA 20166. The associated North American Industry Classification System (NAICS) Code is 325412 – Pharmaceutical Preparation Manufacturing, and the Business Size Standard is 1,300 employees.
The contractor will furnish (including packaging, transportation, manifests, and reports) all PET radiopharmaceuticals listed below to the John D. Dingell VA Medical Center, 4646 John R Street, Detroit, MI 48201 for period of performance October 1, 2026, through September 30, 2027. These are PET radiopharmaceutical supplies used in Nuclear Medicine to perform exams on PET MRI patients.
| Product Name |
| UoM |
| Est. Annual Quantity |
| Cu-64 Dotatate (Detectnet) 3-5 mCi |
| Dose |
| 15 |
| F18 PSMA (Pylarify) 8-10 mCi |
| Dose |
| 120 |
| F18 Fluorodeoxyglucose (FDG) 8-10 mCi |
| Dose |
| 200 |
| F18 Neuraceq 8-10 mCi |
| Dose |
| 20 |
| Pylarify (PSMA) Cancellation Fee |
| N/A |
| 22 |
It is the Government’s belief that Sofie Co. is the only vendor capable of providing all of these specific radiopharmaceuticals for the Detroit VA. Sources sought notice 36C25026Q0931 was sent out to prospective vendors, with a reply window of August 18, 2026 through August 20, 2026. Responses were received from five contractors, including Sofie Co. Contractor capabilities were reviewed, and although the other contractors could provide some of the required products, Sofie Co. was the only contractor capable of providing all of these specific radiopharmaceuticals required by Detroit VA Nuclear Medicine.
This notice of intent is not a request for competitive proposals or quotes. Interested parties may identify their interest and capability to respond to the requirement. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Interested persons may identify their interests and capability to respond to this requirement no later than 4:00 PM Eastern Time, Wednesday, September 23, 2025. Any response to this notice must show clear and convincing evidence that competition would be advantageous to the Government. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to meet the subject requirement. This information shall be provided at no cost or obligation to the Government.
Interest/capability statements shall be submitted to James Howard, Contracting Specialist, via e-mail at james.howard3@va.gov. Telephone inquiries will not be accepted.
Special Notice
File details come from the government source that posted it. Updated .